These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

336 related items for PubMed ID: 7542776

  • 1. Identification of the human prostatic carcinoma oncogene PTI-1 by rapid expression cloning and differential RNA display.
    Shen R, Su ZZ, Olsson CA, Fisher PB.
    Proc Natl Acad Sci U S A; 1995 Jul 18; 92(15):6778-82. PubMed ID: 7542776
    [Abstract] [Full Text] [Related]

  • 2. Human prostatic carcinoma oncogene PTI-1 is expressed in human tumor cell lines and prostate carcinoma patient blood samples.
    Sun Y, Lin J, Katz AE, Fisher PB.
    Cancer Res; 1997 Jan 01; 57(1):18-23. PubMed ID: 8988032
    [Abstract] [Full Text] [Related]

  • 3. Antisense inhibition of the PTI-1 oncogene reverses cancer phenotypes.
    Su Z, Goldstein NI, Fisher PB.
    Proc Natl Acad Sci U S A; 1998 Feb 17; 95(4):1764-9. PubMed ID: 9465091
    [Abstract] [Full Text] [Related]

  • 4. Transient reduction of PTI-1 expression by short interfering RNAs inhibits the growth of human prostate cancer cell lines.
    Yu L, Wu G, Wang L, Wang H, Zhang G.
    Tohoku J Exp Med; 2006 Jun 17; 209(2):141-8. PubMed ID: 16707856
    [Abstract] [Full Text] [Related]

  • 5. Translational infidelity and human cancer: role of the PTI-1 oncogene.
    Gopalkrishnan RV, Su ZZ, Goldstein NI, Fisher PB.
    Int J Biochem Cell Biol; 1999 Jan 17; 31(1):151-62. PubMed ID: 10216950
    [Abstract] [Full Text] [Related]

  • 6. Isolation and characterization of the major form of human MUC18 cDNA gene and correlation of MUC18 over-expression in prostate cancer cell lines and tissues with malignant progression.
    Wu GJ, Wu MW, Wang SW, Liu Z, Qu P, Peng Q, Yang H, Varma VA, Sun QC, Petros JA, Lim SD, Amin MB.
    Gene; 2001 Nov 14; 279(1):17-31. PubMed ID: 11722842
    [Abstract] [Full Text] [Related]

  • 7. A novel human prostate-specific gene-1 (HPG-1): molecular cloning, sequencing, and its potential involvement in prostate carcinogenesis.
    Herness EA, Naz RK.
    Cancer Res; 2003 Jan 15; 63(2):329-36. PubMed ID: 12543784
    [Abstract] [Full Text] [Related]

  • 8. Surface-epitope masking and expression cloning identifies the human prostate carcinoma tumor antigen gene PCTA-1 a member of the galectin gene family.
    Su ZZ, Lin J, Shen R, Fisher PE, Goldstein NI, Fisher PB.
    Proc Natl Acad Sci U S A; 1996 Jul 09; 93(14):7252-7. PubMed ID: 8692978
    [Abstract] [Full Text] [Related]

  • 9. Transfer of a dominant-acting tumor-inducing oncogene from human prostatic carcinoma cells to cloned rat embryo fibroblast cells by DNA-transfection.
    Su ZZ, Olsson CA, Zimmer SG, Fisher PB.
    Anticancer Res; 1992 Jul 09; 12(2):297-304. PubMed ID: 1580547
    [Abstract] [Full Text] [Related]

  • 10. Novel human prostate-specific cDNA: molecular cloning, expression, and immunobiology of the recombinant protein.
    Naz RK, Santhanam R, Tyagi N.
    Biochem Biophys Res Commun; 2002 Oct 11; 297(5):1075-84. PubMed ID: 12372395
    [Abstract] [Full Text] [Related]

  • 11. Deconstructing PTI-1: PTI-1 is a truncated, but not mutated, form of translation elongatin factor 1A1, eEF1A1.
    Mansilla F, Hansen LL, Jakobsen H, Kjeldgaard NO, Clark BF, Knudsen CR.
    Biochim Biophys Acta; 2005 Feb 14; 1727(2):116-24. PubMed ID: 15716006
    [Abstract] [Full Text] [Related]

  • 12. Identification of rapid turnover transcripts overexpressed in thyroid tumors and thyroid cancer cell lines: use of a targeted differential RNA display method to select for mRNA subsets.
    Gonsky R, Knauf JA, Elisei R, Wang JW, Su S, Fagin JA.
    Nucleic Acids Res; 1997 Oct 01; 25(19):3823-31. PubMed ID: 9380504
    [Abstract] [Full Text] [Related]

  • 13. The novel human MOST-1 (C8orf17) gene exhibits tissue specific expression, maps to chromosome 8q24.2, and is overexpressed/amplified in high grade cancers of the breast and prostate.
    Tan JM, Tock EP, Chow VT.
    Mol Pathol; 2003 Apr 01; 56(2):109-15. PubMed ID: 12665628
    [Abstract] [Full Text] [Related]

  • 14. Aberrant methylation and deacetylation of deleted in liver cancer-1 gene in prostate cancer: potential clinical applications.
    Guan M, Zhou X, Soulitzis N, Spandidos DA, Popescu NC.
    Clin Cancer Res; 2006 Mar 01; 12(5):1412-9. PubMed ID: 16533763
    [Abstract] [Full Text] [Related]

  • 15. Tazarotene-induced gene 1 (TIG1) expression in prostate carcinomas and its relationship to tumorigenicity.
    Jing C, El-Ghany MA, Beesley C, Foster CS, Rudland PS, Smith P, Ke Y.
    J Natl Cancer Inst; 2002 Apr 03; 94(7):482-90. PubMed ID: 11929948
    [Abstract] [Full Text] [Related]

  • 16. ZFY gene expression and retention in human prostate adenocarcinoma.
    Tricoli JV, Bracken RB.
    Genes Chromosomes Cancer; 1993 Feb 03; 6(2):65-72. PubMed ID: 7680890
    [Abstract] [Full Text] [Related]

  • 17. The alpha 1C-adrenoceptor in human prostate: cloning, functional expression, and localization to specific prostatic cell types.
    Tseng-Crank J, Kost T, Goetz A, Hazum S, Roberson KM, Haizlip J, Godinot N, Robertson CN, Saussy D.
    Br J Pharmacol; 1995 Aug 03; 115(8):1475-85. PubMed ID: 8564208
    [Abstract] [Full Text] [Related]

  • 18. Neurofilament heavy chain-like messenger RNA and protein are present in benign prostate and down-regulated in prostatic carcinoma.
    Schleicher RL, Hunter SB, Zhang M, Zheng M, Tan W, Bandea CI, Fallon MT, Bostwick DG, Varma VA.
    Cancer Res; 1997 Aug 15; 57(16):3532-6. PubMed ID: 9270025
    [Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 17.